Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e3182333df5
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2011
Authors
Publisher
Elsevier BV